Answers are grounded in this paper and cite their sources.
Comparative analysis reveals varied value perceptions of drug courts in Australia and New Zealand, highlighting methodological impacts.
Economic evaluations are increasingly used to inform investment in justice interventions such as drug courts, yet different methods can produce divergent accounts of the same intervention’s value. This article presents an interpretive, illustrative within-program comparison rather than a comprehensive review, drawing on four economic evaluations of drug courts in Australia and New Zealand: two cost–benefit analyses, one cost–effectiveness analysis and one social return on investment, applied to two matched drug court programs. Using a targeted search and comparative framework, the analysis examines how costing perspective, outcome selection, time horizon, counterfactual construction and treatment of uncertainty shape reported value-for-money. Across both pairs, cost–effectiveness analysis portrays drug courts as effective but relatively costly, cost–benefit analyses reframe them as cost-beneficial public investments and social return on investment presents them as generating high social value. These differences arise less from program performance than from methodological choices and underlying value logics of managerial efficiency, allocative efficiency or social wellbeing. The findings show that economic evaluations in criminal justice help construct value by setting boundaries of what counts as benefit and for whom. The paper argues for multiple-method economic evaluations that align methods with policy intent, recognise long-term societal returns and balance budgetary accountability with community legitimacy in decision-making.
No takes yet. Share an insight, caveat, or question.
Natalia Spivakova (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: